Buy & Sell Booz Allen Hamilton Holding Corporation (BAH) – Booz Allen Hamilton Holding Corporation Price Today
Aura AI Summary
Key Stats
- $9.28BMarket Cap
- IndustrialsSector
- -14.85%3M Drawdown
- $12.68BEnterprise Value
- 3.05%Dividend Yield
- 100% Buy | 0% SellTrading Activity
- 73 daysTypical Hold Time
Booz Allen Hamilton Holding Corporation (BAH) is currently valued at a market capitalization of $9.28B, with an enterprise value of $12.68B. Over the past 52 weeks, Booz Allen Hamilton Holding Corporation has traded between a low of $71.59 and a high of $115.95, highlighting its annual price range. Over the past three months, Booz Allen Hamilton Holding Corporation has recorded a drawdown of -14.85%, reflecting recent price volatility. Booz Allen Hamilton Holding Corporation offers a dividend yield of 3.05%, with the most recent dividend of $0.59 paid on 10 Jun 26. On average, investors hold Booz Allen Hamilton Holding Corporation for approximately 73 days, indicating typical investor behavior on the platform.
About Booz Allen Hamilton Holding Corporation
Booz Allen Hamilton Holding Corp is a provider of management consulting services to the U.S. government. Other services offered include technology, such as cloud computing and cybersecurity consulting, and engineering consulting. The consulting services are focused on defense, intelligence, and civil markets. In addition to the U.S. government, Booz Allen Hamilton provides its management and technology consulting services to large corporations, institutions, and nonprofit organizations. The company assists clients in long-term engagements around the globe.
Most Recent News
Barzolvolimab shows lasting improvement in angioedema for chronic spontaneous urticaria patients, with effects lasting 7 months post-treatment.
Celldex Therapeutics presented long-term Phase 2 results showing barzolvolimab provides rapid, significant, and durable relief from angioedema in patients with moderate to severe chronic spontaneous urticaria (CSU) refractory to antihistamines. Impre...
Verizon and AT&T stocks range-bound amid fiber expansions and mixed earnings outlooks.
Verizon and AT&T are both undergoing aggressive fiber network expansions but show different stock performances. Verizon trades near its 52-week high with improved earnings guidance and positive subscriber growth, while AT&T faces a recent downgrade a...
Medtronic offers steady dividends and growth, ideal for long-term investors aged 50+.
Medtronic, a leading medical device company, reported strong fiscal 2026 growth with $36.36 billion in revenue and a 49th consecutive year of dividend increases, yielding about 3.52%. Its diversified portfolio in cardiovascular, neuroscience, medical...
